GoodRx Holdings, Inc. (GDRX)
NasdaqGS
Price as at 1 Oct 2026, 10:58 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
GoodRx Holdings, Inc. trades at $3.29. We do not hold enough of the inputs to value this company with the confidence the estimate implies, so we publish no fair value for it rather than a number we would not defend.
About GoodRx Holdings, Inc.
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In addition, the company provides healthcare products and solutions for dogs, cats, and other pets. It serves pharmacy benefit managers who manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was founded in 2011 and is headquartered in Santa Monica, California.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
Super investor ownership
9 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- Renaissance Technologies, RENAISSANCE TECHNOLOGIES LLC$9.35M · 0.0% of book
- Cliff Asness, AQR CAPITAL MANAGEMENT LLC$6.70M · 0.0% of book
- Two Sigma, TWO SIGMA INVESTMENTS, LP$2.14M · 0.0% of book
- Marshall Wace, MARSHALL WACE, LLP$1.56M · 0.0% of book
- D. E. Shaw, D. E. Shaw & Co., Inc.$1.38M · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
Politician trades in GDRX
Trades in GDRX disclosed by members of Congress and executive-branch officials, latest first:
- Anthony E. Gonzalez · HouseBuy · $100,001 - $250,000 · traded 25 Mar 2021 · disclosed 23 Apr 2021
A disclosure reports a value band, not an amount, and is due up to 45 days after the trade; some arrive later. Every filer we track, each with their own page, is on the Congress trading tracker.
Common questions
Which funds own GDRX?
9 of the institutions we track reported a position in GDRX in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
Where does SteadyShares get its GDRX data?
Fundamentals for GDRX come from company filings and exchange data, as listed on NasdaqGS; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 10:58 UTC and is delayed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for GDRX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.